NEGRI SERENA

Apostol, A., Gronwald, J., Cybulski, C., Kim, R., Møller, P., Karlan, B., et al. (2026). Risk of Breast Cancer After Ovarian Cancer in Women With a Pathogenic/Likely Pathogenic Variant in BRCA1 or BRCA2. JOURNAL OF CLINICAL ONCOLOGY, 44(10), 883-892 [10.1200/JCO-25-01648]. Detail

Negri, S., Fornari, C., Ye, L., Inzoli, A., Costa, C., Mantovani, L., et al. (2026). Cost-effectiveness analysis (CEA) of ovarian cancer preventive strategies for women with BRCA1/2 pathogenic variants: the role of surveillance. THE EUROPEAN JOURNAL OF HEALTH ECONOMICS [10.1007/s10198-026-01909-4]. Detail

Marino, G., Marchetta, L., Negri, S., Testa, F., Lugotti, D., Cavallo, G., et al. (2025). Oncologic and fertility outcomes in patients with juvenile granulosa cell tumor - a retrospective single centre analysis. GYNECOLOGIC ONCOLOGY, 192(January 2025), 89-93 [10.1016/j.ygyno.2024.11.007]. Detail

Loizzi, V., Comes, M., Arezzo, F., Apostol, A., Bove, S., Fanizzi, A., et al. (2025). Validation of machine learning-based models to predict and explain the risk of ovarian cancer: a multicentric study on BRCA-mutated patients undergoing risk-reducing salpingo-oophorectomy. FRONTIERS IN ONCOLOGY, 15 [10.3389/fonc.2025.1574037]. Detail

Marino, G., Negri, S., Testa, F., Giuliani, D., De Ponti, E., Bombelli, M., et al. (2025). Oncologic and fertility outcome in patients with advanced stage ovarian immature teratomas. GYNECOLOGIC ONCOLOGY REPORT, 58(April 2025) [10.1016/j.gore.2025.101715]. Detail